Myelodysplastic syndromes: review of pathophysiology and current novel treatment approaches.
about
Epigenetic approaches in the treatment of myelodysplastic syndromes: clinical utility of azacitidineHydralazine and magnesium valproate as epigenetic treatment for myelodysplastic syndrome. Preliminary results of a phase-II trialPesticide exposure as a risk factor for myelodysplastic syndromes: a meta-analysis based on 1,942 cases and 5,359 controlsPhase 2 study of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving azacitidine therapyA pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine.Usefulness of magnetic resonance imaging as a prognostic variable in myelodysplastic syndromes.Radiotherapy- and chemotherapy-induced myelodysplasia syndrome: a nationwide population-based nested case-control study.Complete Remission of del(5q) Myelodysplastic Syndrome after 7 Days of Lenalidomide Therapy Gives an Alert!Factors associated with hematopoietic cell transplantation (HCT) among patients in a population-based study of myelodysplastic syndrome (MDS) in Minnesota.Usefulness of spinal magnetic resonance imaging in patients with myelodysplastic syndromes.Flow Cytometry in the Diagnosis of Myelodysplastic SyndromesReview of therapeutic options and the management of patients with myelodysplastic syndromes.The role of magnetic resonance imaging in the evaluation of transfusional iron overload in myelodysplastic syndromesPhenotypic and Cytogenetic Characterization of Mesenchymal Stromal Cells in De Novo Myelodysplastic Syndromes.Investigation of DNA repair gene variants on myelodysplastic syndromes in a Turkish population.
P2860
Q24608659-49F25A09-1B16-46C4-BBB0-42DA13B507D0Q28294892-C60F732D-1515-4537-AF38-794716F15CF9Q28396336-7C2F4D1E-B2E4-4C63-B79A-3DF64860E1F9Q33390778-4728A98A-1CDF-4FCF-B659-C77C713371F4Q33415466-51D39CE4-9C03-47B8-8AE5-E6C0D9AEA980Q33417646-8C3EA26C-44D7-4ECB-9871-6E914EB50C21Q36153838-5AAA84D0-832A-43CB-9784-A8C294829F19Q36422512-5C7BDC79-76DA-4E6E-8026-457662C664CEQ36499044-AF039973-8BA2-47EE-B790-45BA55C2C0EAQ36680303-63FEB80C-65F6-479C-B73C-3F4C9F46126AQ37155338-83BFA661-5DF7-4166-A71D-128DF9FB7C09Q38095121-F1414D55-E376-4E6F-AE1E-5A4974F01529Q41856578-EE6FA858-F327-4FF4-8AF1-4C467446C4B6Q53023244-18063324-2F0A-4093-8652-A921CB1732C9Q54193796-A03A03B0-B7F8-4597-BF88-3A2B62D535C5
P2860
Myelodysplastic syndromes: review of pathophysiology and current novel treatment approaches.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Myelodysplastic syndromes: rev ...... nt novel treatment approaches.
@en
type
label
Myelodysplastic syndromes: rev ...... nt novel treatment approaches.
@en
prefLabel
Myelodysplastic syndromes: rev ...... nt novel treatment approaches.
@en
P1476
Myelodysplastic syndromes: rev ...... nt novel treatment approaches.
@en
P2093
P304
P356
10.2174/156800907781662284
P577
2007-09-01T00:00:00Z